|
[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Murugesan, M. and Premkumar, K. (2021) Integrative miRNA-mRNA Functional Analysis Identifies miR-182 as a Potential Prognostic Biomarker in Breast Cancer. Molecular Omics, 17, 533-543. [Google Scholar] [CrossRef]
|
|
[3]
|
An, M., Zang, X., Wang, J., et al. (2021) Comprehensive Analysis of Differentially Expressed Long Noncoding RNAs, miRNAs and mRNAs in Breast Cancer Brain Metastasis. Epigenomics, 13, 1113-1128. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
He, B., Zhao, Z., Cai, Q., et al. (2020) miRNA-Based Biomarkers, Therapies, and Resistance in Cancer. International Journal of Biological Sciences, 16, 2628-2647. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Ma, J., Huang, W., Zhu, C., et al. (2021) MiR-423-3p Activates FAK Sig-naling Pathway to Drive EMT Process and Tumor Growth in Lung Adenocarcinoma through Targeting CYBRD1. Journal of Clinical Laboratory Analysis, 35, E24044. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
赵楠, 张涛, 魏东, 等. MiR-423-3p通过靶向SUFU调节结肠癌细胞对5-Fu的敏感性[J]. 中国组织化学与细胞化学杂志, 2021, 30(2): 152-158.
|
|
[7]
|
Xu, J., He, J., Huang, H., et al. (2018) MicroRNA-423-3p Promotes Glioma Growth by Targeting PANX2. Oncology Letters, 16, 179-188. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Loibl, S., Poortmans, P., Mor-row, M., et al. (2021) Breast Cancer. The Lancet, 397, 1750-1769. [Google Scholar] [CrossRef]
|
|
[9]
|
Fridrichova, I. and Zmetakova, I. (2019) MicroRNAs Con-tribute to Breast Cancer Invasiveness. Cells, 8, Article No. 1361. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Petri, B.J. and Klinge, C.M. (2020) Regulation of Breast Cancer Metastasis Signaling by miRNAs. Cancer and Metastasis Re-views, 39, 837-886. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Song, M., Liu, J., Zheng, X., et al. (2021) MiR-148a-3p Targets CEMIP to Suppress the Genesis of Gastric Cancer Cells.Biochemical and Biophysical Research Communications, 575, 42-49. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Wang, W., Dong, J., Wang, M., et al. (2018) MiR-148a-3p Suppresses Epithelial Ovarian Cancer Progression Primarily by Targeting C-Met. Oncology Letters, 15, 6131-6136. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Iacona, J.R. and Lutz, C.S. (2019) MiR-146a-5p: Ex-pression, Regulation, and Functions in Cancer. Wiley Interdisciplinary Reviews: RNA, 10, E1533. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Liu, Y., Huang, R., Xie, D., et al. (2021) ZNF674-AS1 Antagonizes MiR-423-3p to Induce G0/G1 Cell Cycle Arrest in Non-Small Cell Lung Cancer Cells. Cell & Molecular Bio Letters, 26, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Liu, Z. and Cui, Y. (2021) Bim’s Effect on the Expression of MiR-423-3p in Promoting Primary Hepatic Cancer (PHC) and Role of MiR-423-3p in PHC Proliferation and Invasion. Biochemical Genetics, 59, 1247-1259. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Guo, T., Wang, Y., Jia, J., et al. (2020) The Identification of Plasma Exosomal MiR-423-3p as a Potential Predictive Biomarker for Prostate Cancer Castration-Resistance Develop-ment by Plasma Exosomal MiRNA Sequencing. Frontiers in Cell and Developmental Biology, 8, Article ID: 602493. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Yan, X., Zhang, S., Jia, J., et al. (2022) Exosomal MiR-423-3p In-hibits Macrophage M2 Polarization to Suppress the Malignant Progression of Cervical Cancer. Pathology—Research and Practice, 235, Article ID: 153882. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Drozak, J., Veiga-Da-Cunha, M., Vertommen, D., et al. (2010) Molecular Identification of Carnosine Synthase as ATP-Grasp Domain-Containing Protein 1 (ATPGD1). Journal of Bi-ological Chemistry, 285, 9346-9356. [Google Scholar] [CrossRef]
|
|
[19]
|
Artioli, G.G., Sale, C. and Jones, R.L. (2019) Carnosine in Health and Disease. European Journal of Sport Science, 19, 30-39. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Xiong, F., Mao, R., Zhao, R., et al. (2022) Plasma Exosomal S1PR5 and CARNS1 as Potential Non-Invasive Screening Biomarkers of Coronary Heart Disease. Frontiers in Cardi-ovascular Medicine, 9, Article ID: 845673. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Horii, Y., Shen, J., Fujisaki, Y., et al. (2012) Effects of L-Carnosine on Splenic Sympathetic Nerve Activity and Tumor Proliferation. Neuroscience Letters, 510, 1-5. [Google Scholar] [CrossRef] [PubMed]
|